NM_000878.5(IL2RB):c.203+1G>A AND Immunodeficiency 63 with lymphoproliferation and autoimmunity

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 10, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003133701.3

Allele description [Variation Report for NM_000878.5(IL2RB):c.203+1G>A]

NM_000878.5(IL2RB):c.203+1G>A

Gene:

IL2RB:interleukin 2 receptor subunit beta [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

22q12.3

Genomic location:

Preferred name:

NM_000878.5(IL2RB):c.203+1G>A

HGVS:

NC_000022.11:g.37143520C>T
NM_000878.5:c.203+1G>AMANE SELECT
NM_001346222.1:c.203+1G>A
NM_001346223.2:c.203+1G>A
NC_000022.10:g.37539560C>T

Molecular consequence:

NM_000878.5:c.203+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001346222.1:c.203+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001346223.2:c.203+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:: Immunodeficiency 63 with lymphoproliferation and autoimmunity
Synonyms:: INTERLEUKIN 2 RECEPTOR, BETA, DEFICIENCY OF; IL2RB DEFICIENCY; CD122 DEFICIENCY
Identifiers:: MONDO: MONDO:0032782; MedGen: C5193126; OMIM: 618495

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003813367	Revvity Omics, Revvity	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Apr 10, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003813367

Revvity Omics, Revvity

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Apr 10, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Revvity Omics, Revvity, SCV003813367.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 16, 2024

ClinVar

Relating variation to medicine